Advocacy intelligence hub — real-time data for patient organizations
Innovaderm Research Inc. — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Robert Bissonnette, MD
Innovaderm Research
Ahmed Hassan Nouh, MD
Al-Azhar university Hospital
Daniel Magilavy, MD
Rigel Pharmaceuticals,Inc.
Christopher T Richardson, MD, PhD
University of Rochester
William Wegener, PhD, MD, MD
Gilead Sciences
📍 BROOMALL, PA
Andrew G Franks, Jr., MD
NYU Langone Health